Roles of periostin in vascular remodeling of allergic granulomatous angiitis in murine model Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation Year: 2012
Osteopontin blockade prevents fibrosis in a murine chronic model of allergic airway disease Source: Eur Respir J 2007; 30: Suppl. 51, 60s Year: 2007
Disruption of CD44 variant 6 abolished bronchial hyperresponsiveness, inflammation and mast cell myositis in a murine model of asthma Source: Eur Respir J 2006; 28: Suppl. 50, 217s Year: 2006
Tiotropium inhibits airway inflammation and goblet cell metaplasia in a model of relapsing asthma in mice Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015
Effect of nilotinib on airway smooth muscle thickening in a murine model of chronic asthma Source: Annual Congress 2012 - New drug targets and pre-clinical models for respiratory diseases Year: 2012
Icaritin inhibited ovalbumin-induced airway inflammation in murine model Source: Virtual Congress 2020 – Clinical and laboratory pharmacology in asthma Year: 2020
Pathogenesis of allergic granulomatous angitis in an experimental model with mice Source: Eur Respir J 2006; 28: Suppl. 50, 227s Year: 2006
Mast cell myositis is associated with airway remodelling in a chronic model of murine asthma Source: Eur Respir J 2006; 28: Suppl. 50, 226s Year: 2006
A phosphatidylinositol 3-kinase Inhibitor strongly suppressed pulmonary vascular remodeling in a murine model of allergic vasculitis Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015
PDE-4-inhibitor rolipram supports treg-mediated suppression in a murine model of allergic airway disease Source: Annual Congress 2008 - Risk factors for asthma versus asthma control Year: 2008
Narirutin inhibits airway inflammation in an allergic mouse model Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010
Anti IL-17 with or without Rho kinase inhibitor in mice with chronic allergic pulmonary inflammation Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology Year: 2017
Effects of prednisolone and imatinib mesylate on inflammation and fibrosis in amiodarone-induced pulmonary toxicity in rats Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010
Stem cell therapy attenuates airway and lung parenchyma remodeling in a murine model of chronic allergic asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008
Circulating fibrocyte recruitment and differentiation inhibited by treprostinil in pulmonary hypertension murine model Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010
Pentoxifylline inhibits the neutrophil alveolitis in a murine ARDS model Source: Eur Respir J 2001; 18: Suppl. 33, 238s Year: 2001
HIF-1α inhibitor, 2ME2, attenuates airway inflammation and hyperresponsiveness in allergic airway disease Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology Year: 2008
Evaluation of apoptosis in inflammatory cells in a model of chronic airway inflammation in guinea pigs: effects of dexamethasone and montelukast treatments Source: Eur Respir J 2003; 22: Suppl. 45, 281s Year: 2003
Therapeutic effect of roflumilast on LPS- and OVA-induced goblet cell hyperplasia in rats Source: Eur Respir J 2007; 30: Suppl. 51, 25s Year: 2007
Steroid-resistant inflammation in a mouse model of severe asthma is not inhibited by the combination of theophylline and budesonide Source: International Congress 2018 – Basic pharmacology Year: 2018